1. Home
  2. GEL vs SUPN Comparison

GEL vs SUPN Comparison

Compare GEL & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEL
  • SUPN
  • Stock Information
  • Founded
  • GEL 1996
  • SUPN 2005
  • Country
  • GEL United States
  • SUPN United States
  • Employees
  • GEL N/A
  • SUPN N/A
  • Industry
  • GEL Oil Refining/Marketing
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • GEL Energy
  • SUPN Health Care
  • Exchange
  • GEL Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • GEL 1.6B
  • SUPN 1.7B
  • IPO Year
  • GEL 1996
  • SUPN 2012
  • Fundamental
  • Price
  • GEL $14.79
  • SUPN $31.70
  • Analyst Decision
  • GEL Buy
  • SUPN Hold
  • Analyst Count
  • GEL 3
  • SUPN 2
  • Target Price
  • GEL $16.50
  • SUPN $36.00
  • AVG Volume (30 Days)
  • GEL 405.8K
  • SUPN 430.1K
  • Earning Date
  • GEL 05-08-2025
  • SUPN 05-06-2025
  • Dividend Yield
  • GEL 4.47%
  • SUPN N/A
  • EPS Growth
  • GEL N/A
  • SUPN N/A
  • EPS
  • GEL N/A
  • SUPN 1.11
  • Revenue
  • GEL $2,930,080,000.00
  • SUPN $667,997,000.00
  • Revenue This Year
  • GEL N/A
  • SUPN N/A
  • Revenue Next Year
  • GEL $1.12
  • SUPN $9.14
  • P/E Ratio
  • GEL N/A
  • SUPN $28.64
  • Revenue Growth
  • GEL N/A
  • SUPN 11.82
  • 52 Week Low
  • GEL $9.86
  • SUPN $25.53
  • 52 Week High
  • GEL $16.44
  • SUPN $40.28
  • Technical
  • Relative Strength Index (RSI)
  • GEL 58.38
  • SUPN 47.88
  • Support Level
  • GEL $13.21
  • SUPN $29.16
  • Resistance Level
  • GEL $14.50
  • SUPN $33.28
  • Average True Range (ATR)
  • GEL 0.49
  • SUPN 1.19
  • MACD
  • GEL 0.05
  • SUPN 0.02
  • Stochastic Oscillator
  • GEL 96.93
  • SUPN 61.65

About GEL Genesis Energy L.P. Common Units

Genesis Energy LP is a limited partnership company that focuses on the midstream segment of the crude oil and natural gas industry. It engages in providing services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are offshore pipeline transportation, sodium minerals, and sulfur services, onshore facilities and transportation, and marine transportation. It generates maximum revenue from the offshore pipeline transportation segment which conducts crude oil and natural gas pipeline transportation and handling operations in the Gulf of Mexico through its offshore pipeline transportation segment, which focuses on providing a suite of services to integrated and large independent energy companies.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: